Patent ID: 7012098

Claim:
A method for treating a cancer in a subject in need of such treatment, said method consisting of administering to the subject an effective amount of a pharmaceutical composition consisting essentially of an inducible nitric oxide synthase selective inhibitor or pharmaceutically acceptable salt thereof or prodrug thereof, wherein the inducible nitric oxide synthase inhibitor is a compound having a structure corresponding to Formula II or a pharmaceutically acceptable salt thereof, wherein X is —S—, R 12 is C 1 R 18 is —OR 24 R 13 is —H, R 14 is —H, R 11 , R 15 , R 16 , and R 17 are —H, R 19 and R 20 —H, R 21 —H, R 22 is —H, R 23 is C 1 alkyl, and R 24 is —H.